Nothing lasts forever, but you’d think the leaded-glass face of a CRT would not be a place you’re likely to see Father Time causing failures. Alas, the particle accelerators we all ...

Maine lawmakers will decide whether to allow optometrists to perform minor eye surgeries, an expansion of their scope of practice that is being opposed by ophthalmologists. The bill, LD 1803, was ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...

Long-term nitrogen dioxide exposure significantly increases cataract surgery risk for urban residents; black carbon correlates with nAMD risk.

The Welsh Government says that it is the eighth month in a row that the waiting list has fallen, but targets for cancer ...

Cataract surgeries at Charlottetown’s outpatient clinic are expected to resume in April, after procedures scheduled for March ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...

California, Florida and Texas each had more than 20 facilities ranked on the “2026 Best Ambulatory Surgery Centers” list published by U.S. News. The publication evaluated more than 4,400 ASCs for ...

In response to the announcement that Alcon, Inc. and Alcon Research, LLC (collectively referred to as Alcon) has abandoned its efforts to purchase LENSAR, Inc. (Lensar), Federal Trade Commission ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...